Crypto News

2 days ago

Acurx Pharmaceuticals (ACXP) Stock Explodes 218% on CDI Clinical Trial Breakthrough

Stocks

Acurx Pharmaceuticals (ACXP) stock jumped 218% after announcing a clinical trial for ibezapolstat, which showed 96% cure rate for C. difficile infection.

The post Acurx Pharmaceuticals (ACXP) Stock Explodes 218% on CDI Clinical Trial Breakthrough appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$ADA$ARB$BITF$BLSH$BMNR$BONK$DBKSF$ENA$LUXFF$MATH$MTT token$NIGHT$PUMP$RAY$S$SEA$SOL$SPACE token$SPTZ$SPX

Latest News